ORDER


References      www. Alzheimers Treatments .com

  1. Greenblatt HM, Kryger G, Lewis T, Silman I, Sussman JL. Structure of acetylcholinesterase complexed with (-)-galanthamine at 3-Å resolution. FEBS Lett 1999 Dec 17;463(3):321-6.
  2. Callahan LM, Chow N, Cheetham JE, Cox C, Coleman PD. Analysis of message expression in single neurons of Alzheimer’s disease brain. Neurobiol Aging 1998 Jan-Feb;19(1 Suppl):S99-105.
  3. Beeri R, Andres C, Lev-Lehman E, Timberg R, Huberman T, Shani M, Soreq H. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr Biol 1995 Sep 1;5(9):1063-71.
  4. Galantamine improves memory and learning ability in Alzheimer’s patients. July 20, 1998. http://www.pslgroup.com/dg/8F5D6.htm
  5. Wessler I, Kirkpatrick CJ, Racke K. The cholinergic “pitfall”: acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol 1999 Mar;26(3):198-205.
  6. Venturi VM, Piccinin GL, Taddei I. Pharmacognostic study of self-sown Galanthus nivalis (var. gracilis) in Italy. Boll Soc Ital Biol Sper 1965 Jun 15;41(11):593-7.
  7. Paskov DS, Stoyanov KA, Saev SK, Tenev KA, Mincheva ML. Clinical experience with Nivalin as anticholinesterase drug in anaesthesiological practice. Proc First Eur Congr Anesthesiol, Vienna, Sep 3-9, 1962.
  8. Cozanitis DA. Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine). Anaesthesist 1977 Dec;26(12):649-50.
  9. Thomsen T, Kewitz H. Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo. Life Sci 1990;46(21):1553-8.
  10. Wake G, Court J, Pickering A, Lewis R, Wilkins R, Perry E. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J Ethnopharmacol 2000 Feb;69(2):105-14.
  11. Ludianskii EA. On the use of anticholinesterase agents in the treatment of neurological diseases. Sov Med 1964 Mar;27:84-7.

BACK

ORDER

Research abstracts
Galantamine: its use in Alzheimer’s
Galantamine: in Alzheimer’s patients
Galantamine: acetylcholinesterase inhibition
Galantamine: therapeutic effects beyond cognition
Galantamine: benefits to Alzheimer’s patients
Galantamine: nicotinic receptors modulation in Alzheimers’s
Galantamine: a study in Alzheimer’s
Galantamine: its effects on Alzheimer’s
Galantamine: a new treatment for Alzheimer’s
Galantamine: effect on nicotinic receptor binding
Galantamine: an allosterically potentiating ligant
Galantamine: nicotinic modulation in an animal model
Galantamine: memory & nicotinic receptors effect in rats
Galantamine: a 6 month study: